Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

63.82 -0.74 (-1.15%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
If You Invested $10,000 in Bristol Myers Squibb 5 Years Ago, This Is How Much You Would Have Today
The stock has been beating the market this year -- and that says a lot. 
Via The Motley Fool
Where Bristol-Myers Squibb Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on Bristol-Myers Squibb (NYSE:BMY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
The competition between pharmaceutical company trials to help the 2% to 3% of the population suffering from chronic psoriasis is heating up.   
Via Benzinga
Is Bristol Myers Squibb Stock a Buy With Its New-Product Sales Soaring?
The biopharma company has a lot riding on its new drugs. 
Via The Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 17 strange trades. 
Via Benzinga
Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript
BMY earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Bristol Myers Snags Narrow Quarterly Beat, Keeps Outlook; But Shares Fall
One of the company's biggest products is facing continued challenges. 
Via Investor's Business Daily
Revlimid Generic Competition, Forex Impacts Bristol Myers' Q3 Sales; Reaffirms FY22 Guidance
 
Via Benzinga
New Data Reinforce Benefits Of Bristol Myers's Opdivo In Earlier Stages Of Melanoma
 
Via Benzinga
Big Tech Misses
Good Morning Everyone! Remember, the bigger the drawdown the better bigger the bounce. 
Via Benzinga
Two Warren Buffett Rules You Should Never Forget
Buffett's strategy for investing can be ideal for risk-averse investors. 
Via The Motley Fool
Nasdaq, S&P 500 Futures Lower Following Alphabet, Microsoft Earnings
Pre-open movers 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Cytokinetics CEO: Why It's OK Not Being An Overnight Success
The company hopes to come out next year with at least one heart-failure drug. 
Via Investor's Business Daily
2 Pharma Stocks With Blockbuster Drugs on the Horizon
Eli Lilly and Bristol Myers Squibb should benefit from two unique therapies. 
Via The Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
The healthcare industry is bursting with prime investment opportunities, even in the current environment. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Don't wait to take a second look at these two no-brainer healthcare buys. 
Via The Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
Procrastination could be problematic with these three bargain stocks. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Legend Biotech's Shares Jumped 14.2% On Tuesday
The company presented news regarding early revenue figures for a multiple myeloma therapy it collaborated on. 
Via The Motley Fool
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
AVEO stock jumped on the news that LG Chem will pay $15/share for Aveo Oncology and make it the centerpiece of a new oncology division. 
Via InvestorPlace
Salesforce Pops As Hedge Fund Starboard Discloses Stake In Software Maker
CRM stock popped after activist investor Starboard Value disclosed that it has taken a stake in the enterprise software maker. 
Via Investor's Business Daily
Jupiter Wellness's Potential New OTC Drug Could Put Some More Joy Back Into Breast Cancer Survivors' Lives
Breast cancer has surpassed lung cancer as the most commonly diagnosed cancer globally as of 2021, according to the American Cancer Society and the International Agency for Research on Cancer.  
Via Benzinga
Steady As She Goes With Healthcare Stocks
Favorable seasonality lies ahead for Q4 with a caveat of Q3 earnings reports. 
Via Talk Markets
3 Fast-Growing Medical Dividend Stocks
Sometimes, the strongest payout growth can be found among the future Dividend Aristocrats, not the current ones. 
Via The Motley Fool
Peering Into Bristol-Myers Squibb's Recent Short Interest
Bristol-Myers Squibb's (NYSE:BMY) short percent of float has risen 4.63% since its last report. The company recently reported that it has 24.18 million shares sold short, which is 1.13% of all regular... 
Via Benzinga
Got $5,000? These 2 Stocks Could Continue Beating the Bear Market.
These two stocks have solid fundamentals and are delivering strong results. 
Via The Motley Fool
The 7 Most Undervalued Value Stocks to Buy Now
Undervalued value stocks remain available even as investors have pivoted toward low-valuation stocks in a volatile year for markets. 
Via InvestorPlace
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
Within the last quarter, Bristol-Myers Squibb (NYSE:BMY) has observed the following analyst ratings: 
Via Benzinga
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
If history is any guide, there may be trouble ahead for shares of Bristol-Myers Squibb (NYSE:BMY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.